Market Overview:
The global post herpetic neuralgia treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of post herpetic neuralgia, rising awareness about available treatments, and growing demand for better-quality therapies. The global post herpetic neuralgia treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into anticonvulsants, skin patch therapy, and other therapies. Anticonvulsants are further sub-segmented into gabapentinoids and non-gabapentinoids. Skin patch therapy is further sub-segmented into lidocaine patches and capsaicin patches. Other therapies include antidepressants (tricyclic antidepressants [TCAs] and serotonin norepinephrine reuptake inhibitors [SNRIs]), opioids (morphine sulfate extended release tablets), topical anesthetics (lidocaine cream), nerve blocks (local anesthetics), intrathecal drug delivery systems (baclofen pump), sympathetic ganglion blocks/stellate ganglion blocks/plexus brachialis injections) etc.
Product Definition:
Post herpetic neuralgia is a complication of shingles, which is a viral infection that causes a rash. Post herpetic neuralgia is a pain that lasts for more than three months after the shingles rash goes away. Treatment may include medicines to help with the pain, skin creams, and sometimes surgery.
Anticonvulsants:
Anticonvulsants are the most commonly used medications for treatment of seizures and epilepsy. They are also used to treat bipolar disorder, migraine, and panic disorders. The global anticonvulsants market is expected to grow at a significant rate over the forecast period owing to increasing prevalence of neurological diseases such as epilepsy, migraine, & panic disorder coupled with growing awareness about these drugs among patients.
Skin Patch:
The skin patch is a method used to treat post herpetic neuralgia. It works by blocking the pain signals from getting to the brain. The device consists of two layers of thin, adhesive plastic films that are separated by an adhesive layer and attached to either side of the neck with Velcro-like material. The procedure takes about 10 minutes and is safe for use in patients aged 12 years and above.
Application Insights:
Based on the application, the global post herpetic neuralgia treatment market is segmented into hospital pharmacies, online pharmacies, retail pharmacies and others. The hospital pharmacy segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as presence of a large patient base with chronic pain conditions and availability of advanced healthcare facilities within a short span of time. In addition, high prevalence rates for drug-resistant epilepsy coupled with increasing awareness about available treatment options are also driving factors for this segment growth.
The online pharmacy is expected to grow at lucrative CAGR during the forecast period owing to several advantages associated with internet accessibility such as ease in access to information regarding health issues including product knowledge along with their benefits which eventually leads towards an increased number of patients visiting online pharma ¢â‚¬â„¢ s compared to brick-and-mortar stores due to convenience.
Regional Analysis:
North America dominated the global post herpetic neuralgia treatment market in 2017. The presence of favorable reimbursement policies, increasing awareness about early diagnosis, and availability of effective treatment for PHN are some factors responsible for its large share. In addition, the high cost of these drugs in this region drives patients to look for cheaper alternatives that provide similar results.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to an increase in patient pool seeking medical assistance due to rising incidence rates of various skin disorders coupled with growing healthcare expenditure levels and improving healthcare infrastructure within this region.
Growth Factors:
- Increasing incidence of post herpetic neuralgia
- Growing awareness about post herpetic neuralgia and its treatment options
- Rising demand for better and more effective therapies for post herpetic neuralgia
- Availability of government funding for research on post herpetic neuralgia treatment options
- Technological advancements in the field of post herpetic neuralgia treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Post herpetic Neuralgia Treatment Market Research Report
By Type
Anticonvulsants, Skin Patch, Other
By Application
Hospital Pharmacies, Online Pharmacies, Retail Pharmacies,
By Companies
Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, Teva, Mylan, Hengrui Medicine,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Post herpetic Neuralgia Treatment Market Report Segments:
The global Post herpetic Neuralgia Treatment market is segmented on the basis of:
Types
Anticonvulsants, Skin Patch, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Online Pharmacies, Retail Pharmacies,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Arbor Pharma
- Assertio Therapeutics
- Endo Pharma
- Teikoku Pharma
- Teva
- Mylan
- Hengrui Medicine
Highlights of The Post herpetic Neuralgia Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anticonvulsants
- Skin Patch
- Other
- By Application:
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Post herpetic Neuralgia Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Post herpetic neuralgia treatment is a combination of medications and therapies that are used to relieve the pain caused by postherpetic neuralgia. Treatment may include medication, physical therapy, and/or surgery.
Some of the major players in the post herpetic neuralgia treatment market are Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, Teva, Mylan, Hengrui Medicine.
The post herpetic neuralgia treatment market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Post herpetic Neuralgia Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Post herpetic Neuralgia Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Post herpetic Neuralgia Treatment Market - Supply Chain
4.5. Global Post herpetic Neuralgia Treatment Market Forecast
4.5.1. Post herpetic Neuralgia Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Post herpetic Neuralgia Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Post herpetic Neuralgia Treatment Market Absolute $ Opportunity
5. Global Post herpetic Neuralgia Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Type
5.3.1. Anticonvulsants
5.3.2. Skin Patch
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Post herpetic Neuralgia Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Online Pharmacies
6.3.3. Retail Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Post herpetic Neuralgia Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Post herpetic Neuralgia Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Post herpetic Neuralgia Treatment Demand Share Forecast, 2019-2026
9. North America Post herpetic Neuralgia Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Online Pharmacies
9.4.3. Retail Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Type
9.7.1. Anticonvulsants
9.7.2. Skin Patch
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Post herpetic Neuralgia Treatment Demand Share Forecast, 2019-2026
10. Latin America Post herpetic Neuralgia Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Online Pharmacies
10.4.3. Retail Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Type
10.7.1. Anticonvulsants
10.7.2. Skin Patch
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Post herpetic Neuralgia Treatment Demand Share Forecast, 2019-2026
11. Europe Post herpetic Neuralgia Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Online Pharmacies
11.4.3. Retail Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Type
11.7.1. Anticonvlsants
11.7.2. Skin Patch
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Post herpetic Neuralgia Treatment Demand Share, 2019-2026
12. Asia Pacific Post herpetic Neuralgia Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Online Pharmacies
12.4.3. Retail Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Type
12.7.1. Anticonvulsants
12.7.2. Skin Patch
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Post herpetic Neuralgia Treatment Demand Share, 2019-2026
13. Middle East & Africa Post herpetic Neuralgia Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Online Pharmacies
13.4.3. Retail Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Post herpetic Neuralgia Treatment Market Size and Volume Forecast by Type
13.7.1. Anticonvulsants
13.7.2. Skin Patch
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Post herpetic Neuralgia Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Post herpetic Neuralgia Treatment Market: Market Share Analysis
14.2. Post herpetic Neuralgia Treatment Distributors and Customers
14.3. Post herpetic Neuralgia Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Arbor Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Assertio Therapeutics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Endo Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Teikoku Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Teva
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Mylan
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hengrui Medicine
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
